MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹9,925 Cr | ₹801,705 Cr | ₹6,737 Cr | ₹533 Cr | ₹44,380 Cr |
What is the latest Appropriations of MANKIND PHARMA ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹9,925 Cr |
| Mar2024 | ₹801,705 Cr |
| Mar2023 | ₹6,737 Cr |
| Mar2022 | ₹533 Cr |
| Mar2021 | ₹44,380 Cr |
How is Appropriations of MANKIND PHARMA Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹9,925 Cr | -98.76 | |
| Mar2024 | ₹801,705 Cr | 11,800.05 | |
| Mar2023 | ₹6,737 Cr | 1,163.76 | |
| Mar2022 | ₹533 Cr | -98.80 | |
| Mar2021 | ₹44,380 Cr | - | |
Compare Appropriations of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹92,671.5 Cr | 9.3% | 7.3% | -2.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 9.3% |
7.3% |
-2.3% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses